Treatments & Services
The Dermatology-Rheumatology Connective Tissue Disease Program provides comprehensive care for patients with autoimmune skin and joint disease such as dermatomyositis, lupus and scleroderma.
The Massachusetts General Hospital IgG4-Related Systemic Disease Program is a national leader in the areas of clinical care and research for this recently recognized condition.
The Massachusetts General Hospital Lupus Program conducts groundbreaking research and takes a multidisciplinary approach to caring for patients with systemic lupus erythematosus (lupus).
The Massachusetts General Hospital Lyme Arthritis Program is recognized internationally for its expertise in researching, diagnosing and treating the manifestations of Lyme disease, including Lyme arthritis.
The Massachusetts General Hospital Rheumatoid Arthritis Program is recognized internationally for its innovative research into this condition and state-of-the-art diagnostic and treatment services.
The Massachusetts General Hospital Rheumatology Musculoskeletal (MSK) Ultrasound Program offers diagnosis and treatment for musculoskeletal pain and disorders such as arthritis and gout.
The Massachusetts General Hospital Scleroderma Program provides expert multidisciplinary care for scleroderma (systemic sclerosis) and conducts research to enhance our understanding of the disease and develop new treatments.
The Massachusetts General Hospital Sjögren's Syndrome Program is conducting promising research while also evaluating, treating and educating patients with Sjögren's syndrome.
The Vasculitis and Glomerulonephritis Center at Mass General conducts leading-edge research and provides specialty care for patients with vasculitis, glomerulonephritis and related conditions.
The Clinical Immunology Laboratory provides both diagnostic and educational services to the Mass General community.